CNTO-5825
Product Specifications
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
CNTO-5825 is a humanized monoclonal antibody inhibitor that targets interleukin-13 (IL-13) . This compound shows potential for research in Th2-type inflammation-related diseases such as asthma and atopic dermatitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog